The world is facing a sustainable development crisis. The 2024 Financing for Sustainable Development Report: Financing for Development at a Crossroads finds that financing challenges are at the heart of the crisis and imperil the SDGs and climate action. The window to rescue the SDGs and prevent a c...limate catastrophe is still open but closing rapidly. Financing gaps for sustainable development are large and growing – the estimates by international organizations and others are coalescing around $4 trillion additional investment needed annually for developing countries. This represents a more than 50% increase over the pre-pandemic estimates. Meanwhile, the finance divide has not been bridged, with developing countries paying around twice as much on average in interest on their total sovereign debt stock as developed countries. Many countries lack access to affordable finance or are in debt distress. Weak enabling environments are preventing progress. Average global growth has declined, while policy and regulatory frameworks still do not set appropriate incentives. Public budgets and spending is not fully aligned with SDGs. Private investors are not incentivised to invest enough in SDGs and climate action. The world is at a crossroads. This is the last chance to correct course if we want to achieve the SDGs by the 2030 deadline. Only an urgent, large-scale and sustainable investment push can help us achieve our global goals. Next year’s Fourth International Conference on Financing for Development in 2025 will be a once in 80-year opportunity to support coherent transformation of financing.
more
Dieses Dokument stellt aktuelle Ergebnisse zum Thema Official Development Assistance (ODA) mit Fokus auf Gesundheit und Deutschland zur Verfügung.
The webpage from Medicines for Malaria Venture (MMV) focuses on efforts to develop and provide child-friendly antimalarial treatments. It highlights the challenges of treating malaria in children, who are among the most vulnerable to the disease, and the need for safe, effective, and easy-to-adminis...ter formulations. MMV collaborates with global partners to ensure access to pediatric antimalarial medicines, such as dispersible tablets and rectal treatments, especially in low-resource settings. The page emphasizes the importance of innovation, accessibility, and partnerships in reducing childhood malaria mortality.
more
Este documento del CLAP/SMR (Centro Latinoamericano de Perinatología) aborda las infecciones de transmisión vertical, es decir, aquellas que se transmiten de la madre al niño durante el embarazo, el parto o el período neonatal. Se presenta una tabla detallada con distintos agentes infecciosos (c...omo VIH, sífilis, toxoplasmosis, hepatitis B y C, citomegalovirus, entre otros), describiendo su forma de transmisión, diagnóstico, prevención, tratamiento y seguimiento.
Además, se destacan estrategias sistemáticas de tamizaje materno y neonatal, intervenciones prenatales y postnatales, así como recomendaciones específicas para cada patógeno. El objetivo es reducir los resultados adversos perinatales mediante intervenciones basadas en la evidencia y adaptadas al contexto latinoamericano.
more
The MSF malaria guidelines provide practical, evidence-based recommendations for diagnosing, treating, and preventing malaria, especially in low-resource settings. They cover uncomplicated and severe cases, recommend rapid tests and artemisinin-based therapies, and include special guidance for vulne...rable groups like children and pregnant women.
more
La page du site VIDAL intitulée « Paludisme : traitement – Recommandations » présente les recommandations actuelles pour la prise en charge du paludisme. Elle détaille les différents traitements selon le type de paludisme (P. falciparum ou non), la gravité de l'infection (simple ou sévère...) et le contexte (enfants, femmes enceintes, zones de résistance). Elle aborde également les protocoles de traitement, les médicaments recommandés (comme l'artéméther-luméfantrine ou l'atovaquone-proguanil), ainsi que les précautions à prendre en cas d’automédication ou de voyage en zone endémique.
more
Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of the burden in these areas is due to infection with P...lasmodium falciparum. Artemisinin-based combination therapy (ACT) has been recommended as first-line treatment for uncomplicated P. falciparum malaria in all populations, including pregnant women in their second and third trimesters, since 2006. However, for women in their first trimester of pregnancy, WHO recommended as first-line treatment a combination of quinine and clindamycin.
Based on a review of the evidence conducted in 2022, WHO now recommends artemether–lumefantrine, the ACT with the most human safety data available, as the preferred treatment for uncomplicated P. falciparum malaria in the first trimester of pregnancy. This document presents all relevant evidence on the effects and safety in early pregnancy of artemisinins and partner medicines used in ACTs from both studies in experimental animals and observational studies in humans.
more
Government spending on health from domestic sources is an important indicator of a government's commitment to the health of its people, and is essential for the sustainability of health programmes. We aimed to systematically analyse all data sources available for government spending on health in dev...eloping countries; describe trends in public financing of health; and test the extent to which they were related to changes in gross domestic product (GDP), government size, HIV prevalence, debt relief, and development assistance for health (DAH) to governmental and non-governmental sectors.
more
Background
Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017.
Methods
Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators.
Findings
After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million).
Interpretation
Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention.
Funding
Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health.
more
Dieses Dokument bietet eine Problemanalyse der US-Kürzungen im Bereich globale Gesundheit und leitet daraus konkrete Handlungsempfehlungen für medizinische Akteure ab. Im Fokus steht die Analyse der direkten Auswirkungen auf die gesundheitsspezifische Entwicklungszusammenarbeit.
Diese zweiseitige Kurzfassung bietet eine Problemanalyse der US-Kürzungen im Bereich globale Gesundheit und leitet daraus konkrete Handlungsempfehlungen für medizinische Akteure ab. Im Fokus steht die Analyse der direkten Auswirkungen auf die gesundheitsspezifische Entwicklungszusammenarbeit.
This publication provides a problem analysis of the U.S. cuts in global health and derives concrete recommendations for action for medical actors. The focus is on analyzing the direct effects on health-specific development cooperation.
This two-page summary provides a problem analysis of the U.S. cuts in global health and derives concrete recommendations for action for medical actors. The focus is on analyzing the direct effects on health-specific development cooperation.
Pre-service education sets the foundation for preparing health professionals to provide services within health systems. Educating medical and nursing students to provide mental health, neurological and substance use care: A practical guide for pre-service education provides a practical framework for... enhancing first-degree medical and nursing education in mental, neurological and substance use (MNS) care. It outlines how to integrate 12 core competencies into curricula, offering guidance for universities, educators, and workforce planners. The guide emphasizes competency-based education that equips future doctors and nurses with the attitudes, knowledge, and skills needed to provide quality care for people with MNS conditions.
more
Diese Publikation erklärt anhand von Grafiken die Wichtigkeit von Entwicklungszusammenarbeit im Allgemeinen und für Gesundheit im Speziellen. Denn finanzielle Beiträge im Rahmen der Entwicklungszusammenarbeit haben sich in den letzten Jahrzehnten als unerlässlich, wirksam, günstig und verantwor...tungsvoll erwiesen.
more
This publication uses graphics to explain the importance of development cooperation in general and for health in particular. Financial contributions in the context of development cooperation have proven to be indispensable, effective, affordable and responsible in recent decades.
L’article « Traitement du paludisme d’importation de l’enfant » sur le site Pas à Pas en Pédiatrie traite de la prise en charge médicale du paludisme chez les enfants revenant de zones endémiques. Il décrit les différents types de paludisme, les symptômes à reconnaître, les critère...s de gravité, ainsi que les traitements recommandés selon les formes cliniques et l’espèce de Plasmodium en cause. L’accent est mis sur l’importance du diagnostic rapide et de l’adaptation de la prise en charge aux recommandations françaises.
more
It was a difficult time to be a child in 2024. With deepening violent conflict, climate shocks and poverty, children faced skyrocketing needs while the resources to respond continued to shrink.
But as this year’s Annual Report shows, across more than 190 countries and territories, UNICEF was t...here, saving and uplifting the lives of millions of children – even in the hardest-to-reach places. Together with our partners, we delivered clean water and sanitation, protection and psychosocial support, health, nutrition, and immunization services, and education and skills development.
The world in 2025 continues to be one of significant political shifts and volatility, economic uncertainty and deepening humanitarian crises. To succeed, UNICEF must be at its best.
But announced and anticipated funding cuts are limiting UNICEF’s ability to reach millions of children in dire need. These new cuts are creating a global funding crisis that will put the lives of millions of additional children at risk.
more